Eris Lifesciences Limited, a active public limited company, was established on 25 January 2007 in Ahmedabad, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: L24232GJ2007PLC049867. Registered under ROC Roc Ahmedabad. it is listed on BSE: 540596 and NSE: ERIS. It has an authorized capital of ₹30.00 Cr and a paid-up capital of ₹13.62 Cr.
Formerly known as Eris Lifesciences Private Limited, Eris Lifescience Private Limited. It upholds a compliant status. In 2023, it reported revenue of ₹1,347.99 Cr and a net worth of ₹2,221.88 Cr. Employing 3,131 professional, Its leadership includes Krishnakumar Vaidyanathan (Whole-Time Director), Rajeev Dalal (Director), Inderjeet Singh Negi (Whole-Time Director). Past directors included Kirit Nanubhai Shelat, Vijaya Sampath, Krishnakumar Vaidyanathan. It holds ₹1,524.82 Cr open charges and ₹1,252.50 Cr settled loans. Its latest AGM occurred on 25 September 2024, with the balance sheet filed on 31 March 2024. It is based at Shivarth Ambit, Plot No 142/2, Ramdas Road Off Sbr Near Swati Bungalows, Bodakdev, Ahmedabad, Gujarat, 380054.
L24232GJ2007PLC049867
049867
25 January 2007
₹30.00 Cr
₹13.62 Cr
Roc Ahmedabad
Listed (BSE: 540596, NSE: ERIS)
Active
Explore comprehensive insights into Eris Lifesciences Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Krishnakumar Vaidyanathan | Whole-Time Director | 20 Dec 2020 | Current |
| Rajeev Dalal | Director | 19 Dec 2020 | Current |
| Inderjeet Singh Negi | Whole-Time Director | 25 Jan 2007 | Current |
| Kalpana Vasantrai Unadkat | Director | 05 Jan 2021 | Current |
| Prashant Gupta | Director | 30 Apr 2018 | Current |
| Amit Indubhushan Bakshi | Managing Director | 27 Jan 2007 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 11 Sep 2020 | Past |
| Pramod Abcsdd | Director | 19 Jul 2022 | Past |
| Pramod Abcsdd | Additional Director | 01 Sep 2021 | Past |
| Pramod Abcsdd | Additional Director | 01 Sep 2021 | Past |
| Pramod Abcsdd | Director | 03 Feb 2017 | Past |
| Pramod Abcsdd | Director | 26 May 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Eris Lifesciences Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 8.3% increase. The company also saw a slight decrease in profitability, with a 4.6% decrease in profit. The company's net worth Soared by an impressive increase of 15.81%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Eris Lifesciences had a promoter holding of 52.86% and a public holding of 47.14%. The company had 6 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹15,248,200,000.00
₹12,525,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Apr 2025 | Hdfc Bank Limited | ₹150.00 Cr | Open |
| 27 Dec 2023 | Hdfc Bank Limited | ₹212.00 Cr | Open |
| 21 Dec 2023 | Citi Bank N.A. | ₹280.00 Cr | Open |
| 21 Aug 2023 | Citi Bank N.A. | ₹120.82 Cr | Open |
| 26 Jul 2023 | Axis Bank Limited | ₹337.00 Cr | Open |
Explore comprehensive loan charge details -
Eris Lifesciences has a workforce of 3131 employees as of Mar 06, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Eris Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eris Lifesciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 150.00 Cr with Charge ID 101091534 was registered on 04 Apr 2025. was documented.
Progress on A charge registered on 13 Feb 2024 via Charge ID 100890095 with Others was fully satisfied on 21 Feb 2025. was documented.
Eris Lifesciences Limited last Annual general meeting of members was held on 25 Sep 2024 as per latest MCA records. was recorded as a recent event.
Eris Lifesciences Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was recorded as a recent event.
The activity A charge with Others amounted to Rs. 437.50 Cr with Charge ID 100890095 was registered on 13 Feb 2024. was completed.
The activity A charge with Hdfc Bank Limited amounted to Rs. 212.00 Cr with Charge ID 100838342 was registered on 27 Dec 2023. was completed.
The CIN of Eris Lifesciences Limited is L24232GJ2007PLC049867.
Eris Lifesciences Limited is headquartered at Shivarth Ambit, Plot No 142/2, Ramdas Road Off Sbr Near Swati Bungalows, Bodakdev, Ahmedabad, Gujarat, 380054.
Eris Lifesciences Limited was incorporated on 25 January 2007.
The current directors of Eris Lifesciences Limited are
The primary industry of Eris Lifesciences Limited is Manufacturing.
Eris Lifesciences Limited is listed. It is listed on BSE: 540596 and NSE: ERIS.
The authorized capital of Eris Lifesciences Limited is ₹30.00 Cr, and the paid-up capital is ₹13.62 Cr.
The compliance status of Eris Lifesciences Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX